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Abstract  
Hallucinations constitute one of the five symptom domains of psychotic disorders in DSM-5, 
suggesting diagnostic significance for that group of disorders. Although specific featural 
properties of hallucinations (negative voices, talking in the third person, and location in 
external space) are no longer highlighted in DSM, there is likely a residual assumption that 
hallucinations in schizophrenia can be identified on the basis of these candidate features. We 
investigated whether certain featural properties of hallucinations are specifically indicative 
of schizophrenia by conducting a systematic review of studies showing direct comparisons 
of the featural and clinical characteristics of (auditory and visual) hallucinations among two 
or more population groups (one of which included schizophrenia). A total of 43 articles were 
reviewed which included hallucinations in 4 major groups (non-clinical groups, drug- and 
alcohol-related conditions, medical and neurological conditions, and psychiatric disorders). 
The results showed that no single hallucination feature or characteristic uniquely indicated a 
diagnosis of schizophrenia, with the sole exception of an age of onset in late adolescence. 
Amongst the 21 features of hallucinations in schizophrenia considered here, 95% were 
shared with other psychiatric disorders, 85% with medical/neurological conditions, 66% with 
drugs and alcohol conditions, and 52% with the non-clinical groups. Additional differences 
rendered the non-clinical groups somewhat distinctive from clinical disorders. Overall, when 
considering hallucinations, it is inadvisable to give weight to the presence of any featural 
properties alone in making a schizophrenia diagnosis. It is more important to focus instead 
on the co-occurrence of other symptoms and the value of hallucinations as an indicator of 
vulnerability. 
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1. Introduction 
The personal, cultural, and clinical significances of hallucinations have changed in the two 
hundred years since they were defined by Esquirol as ‘the intimate conviction of actually 
perceiving a sensation for which there is no external object’1, 2. There is a growing 
recognition that hallucinatory experiences attend a wide variety of psychiatric diagnoses and 
can be part of everyday experience for people who do not meet criteria for mental illness. 
For the experiencer, hallucinations can have important personal meanings, and for clinicians 
they are also significant in varied ways, including as diagnostic symptom and as factors 
which may impact on functioning and prognosis, and therefore potentially the necessity of 
treatment.  
Since the earliest clinical texts, auditory hallucinations have been closely linked to 
schizophrenia3 4. Hallucinations constitute one of the five domains of abnormality of 
schizophrenia spectrum and other psychotic disorders in DSM-5. While not diagnostic of 
schizophrenia when occurring in isolation, the presence of persistent auditory hallucinations 
is sufficient for a diagnosis of Other Specified Schizophrenia Spectrum and Other Psychotic 
Disorder, if it is combined with clinically significant distress or functional impairment (5, p. 
122). 
The emphasis on the clinical significance of hallucinations in DSM-55 requires closer 
examination given our growing understanding of hallucinations that feature outside of 
psychosis. It is increasingly recognised that hallucinations occur with significant frequency 
in other psychiatric (e.g., PTSD, personality disorders) and medical conditions 
(neurodegenerative conditions and eye disease), and that they are especially predictive of 
multimorbid psychopathology6 7. A predominant view, however, is that some features of 
hallucinations may distinguish schizophrenia and related disorders from other conditions. 
Candidate distinguishing features which have become important diagnostically include 
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negative and derogatory auditory hallucinations; command hallucinations; voices heard 
conversing about the individual in the third person; and location in external space 4, 5, 8.  
Given the status of hallucinations as diagnostic markers in DSM-5, there is a pressing 
need to establish their specificity to psychotic disorders, particularly through comparison of 
their featural properties across different population groups. This exercise is also essential if 
we are to understand how hallucinations function in cognitive and neuroscientific models of 
psychiatric disorders such as schizophrenia.  
 The present article attempts to meet this challenge through a systematic review of 
empirical studies that have made direct comparisons of hallucinations involving two or more 
population groups (one of which included schizophrenia). Our focus is on visual and 
auditory hallucinations, since these experiences figure more prominently in schizophrenia 
research than other modalities of hallucination. We place particular emphasis on whether 
hallucinations share points of commonality or divergence between different groups. Since 
diagnostic criteria inevitably focus on self-report rather than objective markers, the bulk of 
studies have reported on the phenomenological features of hallucinations. Too few studies 
have directly compared cognitive or neuroimaging variables between two or more groups for 
meaningful analyses, although helpful syntheses of the literature exist (9-12). In this paper, we 
present a direct contrast of hallucination features across clinical groups with a view to 
identifying features specific to schizophrenia. First, we briefly consider the different 
conditions and groups in which hallucinations have been reported.   
 
2. Disorders and conditions in which hallucinations present  
There are many disorders and conditions (including non-pathological cases) in which 
hallucinations have been reported (Supplementary Material Table 1, adapted13 14 15).  
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Psychotic experiences occur in around 4–7% of the general population16, 17, proving 
transitory in around 80% of cases18. In this group, incidence of hallucinations varies with 
developmental stage, appearing with relatively high prevalence in children (8%19) and older 
adults (community 1%–5%; residential care 63%20), and some adults on a continuum of 
hallucination-proneness. Hallucinations also occur transiently in situations causing extreme 
physiological or psychological stress (fatigue, sensory deprivation, bereavement, etc.)21, 22.   
Hallucinations co-occur with toxin- , alcohol- and drug-related conditions that affect 
the central nervous system and involve the cortical sensory areas. These include intoxication 
with stimulants, hallucinogenic drugs, and cannabis, and withdrawal from substances 
including alcohol23. Medication-induced hallucinations also result from drug abuse or occur 
as side-effects of attention-deficit/hyperactivity disorder (ADHD) drugs24, anti-malarial 
medication25, and antiparkinsonian drugs. In these cases, hallucinations usually disappear 
after withdrawal of the substance.  
 Hallucinations are associated with a range of medical conditions. Conditions causing 
interference with, or damage to, the peripheral sensory pathways can produce hallucinations. 
For example, acquired deafness is a common cause for (auditory) hallucinations, as is eye 
disease or lesions of afferent visual pathways for visual hallucinations26 27. Endocrine-related 
metabolic disorders including disorders of thyroid function28 and Hashimoto disease29 can 
produce hallucinations, as can deficiencies in D and B12 vitamins30, 31.  Other medical 
conditions associated with hallucinations include chromosomal disorders, such as Prader–
Willi syndrome32, autoimmune disorders33, and acquired immunodeficiency disorders like 
HIV/AIDS34, as well as sleep disorders like narcolepsy35. Neurological events such as 
tumors36, 37, traumatic brain injuries38, epilepsy39, and cardiovascular events may also cause 
hallucinations where activity involves the brainstem regions and areas involving the 
temporal, occipital, or temporo-parietal pathways.  Hallucinations are also fairly common in 
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neurodegenerative conditions, particularly in Parkinson’s disease40 and Dementia with Lewy 
Bodies41.  
  Finally, hallucinations are reported in a range of major psychiatric conditions. In 
addition to psychotic disorders (schizophrenia, schizotypal personality traits, schizoaffective 
disorders, other specified spectrum disorders, etc.), hallucinations and other psychotic 
experiences occur in affective disorders such as bipolar (mixed, manic, depressed) and 
unipolar depression42; personality disorders; post-traumatic stress disorder; and anorexia and 
bulimia nervosa43. 
 In summary, since hallucinations occur in a number of different clinical groups, they 
can be considered non-specific for psychotic disorders. A categorical approach reliant solely 
on the presence of hallucinations is therefore not helpful as a diagnostic aid. 
 
3. How do hallucinations present across diagnostic classes?  
In this section, we consider data as they inform on points of commonality and divergence 
across diagnostic classes of psychiatric illness, with a particular focus on comparisons with 
schizophrenia spectrum disorders. A predominant aim is to determine which, if any, features 
of hallucinations are pathognomonic: that is, specific to schizophrenia (as the ‘prototypical’ 
psychotic disorder), and not reported in any other population group.  
Methods 
To answer these questions, a search was carried out in Medline for English language 
papers published in peer-reviewed journals containing the following terms (Hallucinat* OR 
Psychot* Symptom*) AND (Compar* OR Differen* OR Similarit* OR Contrast*), without 
date restrictions. Inclusion criteria included empirical papers involving direct contrasts 
between two or more population groups with hallucinations, where one of these groups 
included schizophrenia. Exclusion criteria were: single case studies and reviews, studies 
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reporting on ‘hallucination proneness’ as a continuous variable, and publication in languages 
other than English. The search was conducted on 20 June 2016, and revealed 165 papers, to 
which 21 additional papers were added from known articles and cross-referencing. Title and 
abstracts, and subsequently the entire papers, were scanned to ascertain whether they 
fulfilled the criteria (see Figure 1 for PRISMA diagram). A total of 56 papers met the 
criteria.  
--- Figure 1 here --- 
 
The great majority of papers (90.1%) demonstrated a focus on featural or clinical 
characteristics of hallucinations. The remaining papers reporting solely on imaging data (n 
=4) or cognitive processes (n= 2) were excluded. Seven further papers were excluded for not 
involving a schizophrenia group or not reporting on hallucinations specifically.  
In total 43 articles were reviewed (see Table 1). Papers involving direct comparisons 
with schizophrenia included the following four major groups: (1) non-clinical groups 
(general population44-48, religious experiences49, 50; total 7 studies); (2) drug- or alcohol-
related (substances) conditions51-59 (9 studies); (3) medical and neurological conditions 
(tinnitus60, epilepsy61, 62, narcolepsy35, other medical and neurological causes53, 63-66; total 9 
studies); and (4) psychiatric disorders (affective disorders8, 42, 53, 64, 66-70, borderline 
personality disorder71-74, PTSD75, 76, dissociative identity disorder44, 77, anorexia and 
bulimia78; total 18 studies). There were a further 2 papers on attenuated psychosis (ultra-high 
risk) 79 80, which were classed in the psychiatric group. Noticeably absent were direct 
comparisons with Parkinson’s disease and other neurodegenerative conditions. Given this 
important gap, we chose to include one recent review comparing visual hallucinations in 
schizophrenia to those in Parkinson’s Disease, Lewy Body Dementia, and eye disease81 
(classed in the medical and neurological category).  
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Results 
Findings are organized around the 21 most commonly described features of 
hallucinations in schizophrenia, sorted according to modality, form, content, interference, 
and lack of control82, and other clinical and epidemiological features.  Percentages (when 
available) are shown in Table 1. An entry of ‘nil’  indicates that this feature has not been 
reported in this diagnostic group. 
--- Table 1 here---- 
Overall, psychiatric disorders shared the most features with schizophrenia (20/21, 95%); 
followed by medical/neurological disorders, with 18/21 features of commonality (85%); and 
by substances-related conditions (11/21, 66%). Non-clinical groups shared approximately 
half of all features (11/21, 52%).  
 Auditory (verbal and other sounds) hallucinations occurred in all four major groups, 
with the highest prevalence (outside schizophrenia) reported in evangelical born-again 
Christians (58%)50 and bipolar disorder (57%)42. The predominance of auditory 
hallucinations over other modalities (e.g., visual hallucinations) is commonly viewed as 
indicative of schizophrenia5, although this profile is also reported in medical conditions 
including temporal lobe epilepsy83, as well as in bipolar disorder42.   
Multiple modalities of hallucinations (>3, although not simultaneously) were 
originally thought to be distinctive for schizophrenia66 64, but this pattern also occurs in the 
context of drugs and alcohol55, and narcolepsy35. Psychiatric conditions such as bipolar 
disorder and dissociative identity disorder77 report several modalities of hallucinations 
(typically 2 or 3), but generally fewer than schizophrenia (where individuals may report 4 or 
5 distinct modalities). 
Specific formal parameters of hallucination (persistent voices, vividness and realism, 
and origin in external space) are also displayed in the four major groups. For example, 
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continuous voices over several hours amongst those who have hallucinations have been 
reported in non-clinical individuals at rates of 47%44, tinnitus (70%)60, dissociative identity 
disorder (93%44), and affective disorders (77%69). Similarly, (visual) hallucinations in 
Parkinson’s disease may last for hours at a time84. The experience is highly vivid and 
perceived to be real in 26% of alcohol withdrawal cases56, bipolar disorder (100%69), and 
PTSD (54%76). Voices originating in external space are not pathognomonic of schizophrenia, 
occurring at rates of 57% in non-clinical groups44, 37% in tinnitus60, 60% in PTSD,76 83% in 
bipolar disorder66 69 64, and 67% in dissociative identity disorder44.  
Third-person hallucinations and voices commenting or conversing with each other do 
not distinguish between groups. Voices commenting are reported in non-clinical groups 
(41% of those who hear voices)44, as well as in patients with narcolepsy (17%)35, 
dissociative identity disorder (80%)44, and bipolar disorders (54%)69. Similarly third-person 
hallucinations are reported at rates of 20% in non-clinical groups44 45, 10% in narcolepsy35, 
25%–60% in alcohol withdrawal56 53, and 40% in affective disorders69. Approximately one 
third of individuals with schizophrenia expect their voices to be heard by others85, a feature 
additionally observed in bipolar disorder and organic psychosis66 86.  
With regard to contents, negative, accusatory, or derogatory voices occur in all groups, 
for example 93% of individuals with dissociative identity disorder with hallucinations, 58% 
of affective disorders69, and 62% of PTSD76. Negative contents are also common in both 
auditory and visual hallucinations in alcohol withdrawal56 87, and in neurodegenerative 
conditions84. Negative voices occur less frequently in non-clinical groups, although they are 
still reported in approximately half48 44 of these individuals.  
Similarly, personification and attribution of hallucinations did not distinguish between 
groups. Non-clinical groups often attribute their voices to a relative or acquaintance45, to 
deceased persons, and to religious figures46, whereas personification to supernatural entities 
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is more common in religious experiences50, substance-related conditions55, and psychiatric 
disorders76. In Parkinson’s disease and dementia, hallucinations are attributed to people who 
may be familiar or not, alive or deceased, or to guardian angels81.  
Hallucinations assigned special significance are common in the context of drugs54, 
temporal lobe epilepsy62, bipolar disorder64, and borderline personality disorder71. Such 
special significances are also reported in religious experiences49 50, although the 
interpretation is more positive than for those in schizophrenia.  
Voices giving commands to commit aggressive or injurious actions are observed in all 
groups. For example, in a PTSD sample, 62% of those hearing voices were commanded to 
self-harm, while 46% had acted on command hallucinations75, 76. Command hallucinations 
are also reported in 82.3% of individuals with bipolar disorder69. No data are reported on this 
feature in non-clinical individuals. 
Interference with daily life, and lack of perceived control, is a prominent issue in all 
but non-clinical groups. For example, daytime interference is reported in 84% of individuals 
with dissociative identity disorder44. Similarly, lack of control over the onset and content of 
hallucinations is common with substance-related, medical, and neurological causes60, as well 
as borderline personality disorder72 and bipolar disorder44. By contrast, non-clinical groups 
report significantly less distress or daytime interference than individuals with 
schizophrenia44, and greater levels of control45.  
A persistent course of hallucinations (lasting for more than 1 year, or multiple 
episodes) has been demonstrated in non-clinical groups47, epilepsy83, bipolar disorder88, and 
PTSD in which hallucinations can persist for longer than 1 year in the majority of cases76. In 
Leudar et al.’s sample of 13 non-clinical individuals48, recurrent voice hallucinations were 
reported in 89%, and had been ongoing on average for longer than 4 years. 
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Finally, shared epidemiological and clinical features of hallucinations include the 
following: (i) hearing or vision loss as a vulnerability factor for hallucinations, which is 
additionally reported in UHR groups79, neurological conditions including tinnitus60, and 
neurodegenerative conditions such as Parkinson’s disease81; (ii) negative life events such as 
emotional neglect and trauma, reported in non-clinical groups (50%)44 and psychiatric 
conditions including dissociative identity disorder (50%)44, 77 and borderline personality 
disorder72, 73; (iii) triggers that include exogenous (external) situations in dissociative identity 
disorder (at rates of 80%44) and affective disorders69 but not non-clinical groups44; and 
endogenous (internal) triggers such as sadness, stress, and tiredness reported in the 
nonclinical group44, PTSD (60%)76, and tinnitus60; and (vi) family history of psychiatric 
illness, which is displayed across all major groups except non-clinical groups. 
One feature of hallucinations appears to distinguish schizophrenia from other groups. 
Age of onset of hallucinations in schizophrenia is typically from the late teens to early 
twenties. Direct comparison demonstrates that an earlier age of onset (< 12 years) is more 
frequent in dissociative identity disorder (33%) and non-clinical groups (40%) than in 
schizophrenia (11%)44. Daalman et al.45 showed a mean age of onset of 12.4 years for non-
clinical individuals compared to 21.4 years in schizophrenia. Hallucinations in affective 
disorders, neurological disorders, and alcohol-related conditions, by contrast, appear 
predominantly in middle or older age62 56. 
 
4. Discussion of findings 
Our systematic review demonstrates that almost all phenomenological, clinical, and 
epidemiological features of hallucinations in schizophrenia are also represented in other 
population groups, with the sole exception of age of onset.  
Points of similarity and difference among diagnostic classes 
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Our findings did not support the notion that some features of hallucinations are 
uniquely diagnostic of schizophrenia89 4, 8. Auditory ‘verbal’ hallucinations which are vivid, 
occur frequently, and are experienced as coming from outside of the head are present in all 
four major groups considered here (non-clinical, substances, medical or neurological, and 
psychiatric). Examples include hallucinations linked to religious experiences49, 50, 
dissociative identity disorder44, 77, and temporal lobe epilepsy62, 90. Of note, voices 
originating in external space occurred in half of non-clinical voice-hearers44, one third of 
individuals with tinnitus60, and in 60–83% of individuals with PTSD80, bipolar disorder73 and 
dissociative identity disorder44. The highlighting of Schneider’s first-rank symptoms 
(including third-person hallucinations and voices conversing) as indicative of schizophrenia4 
was not supported, with these features occurring in non-clinical samples at rates of 20%–
40%44, 45, narcolepsy (17%–20%)35, alcohol withdrawal (26–60%)53, 56, affective disorders 
(20%–55%)69, and dissociative identity disorder (80%)44. 
Similarly, the widely held notion that negative voices are indicative of psychosis91 was 
not confirmed. Negative and derogatory (visual and/or auditory) hallucinations occurred in 
all (clinical and non-clinical) groups. Similarly, the way in which hallucinations are 
personified and assigned special significance (i.e., seen as personally meaningful) is also a 
feature of other psychiatric conditions (bipolar disorder, borderline personality disorder, 
PTSD)64, 71, 76, and temporal lobe epilepsy62. In non-clinical groups (such as evangelical 
born-again Christians) it is also common for voices to be interpreted as having religious 
meaning49, 50. Altogether, the featural properties of hallucinations carry minimal information 
about the condition in which it occurs.  
Only one feature, age of onset, was identified as of potential interest for distinguishing 
schizophrenia from other groups. We note, however, that this relates to a continuous variable 
rather than a clear presence or absence of any hallucination feature. Its diagnostic value is 
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further limited given the small number of studies that have considered it transdiagnostically, 
the potential confound of prodromal symptoms predating the onset of frank psychosis, 
potential unreliability of reports due to difficulties in remembering a first experience which 
might have occurred many years ago, and the relatively high variance in age of onset even in 
schizophrenia.  
 With regard to points of rarity among other groups, one feature deserving of more 
research concerns external triggers for hallucination. External triggers, including a lack, or 
an excess, of external stimulation (e.g., social contact), is a trigger in 80% of schizophrenia 
cases92, and similar rates have been reported in dissociative identity disorder and affective 
disorders44, 69. By contrast, there is an absence of information regarding external triggers  in 
non-clinical groups on the basis of the one direct comparison study reviewed here44. We note 
however that one small qualitative study investigating ‘out-of-the-ordinary’ experiences 
including hallucinations93 showed triggering by social isolation.  
Points of rarity for major diagnostic groups 
 We also examined points of rarity for each major group. A historical focus on the 
symptoms of psychosis has reinforced a ‘schizophrenia-centric’ approach to hallucination 
descriptions, yet our analysis allows an examination of each disorder group individually. 
Specifically, Table 1 enables an inspection of how hallucination features are shared among 
diagnostic groups, indicating possible points of rarity.  
With regard to hallucinations in psychiatric disorders (particularly affective disorders, 
borderline personality disorder, dissociative identity disorder, and PTSD), Table 1 suggests 
that no hallucination feature differentiated them from schizophrenia except age of onset 
(95% feature commonality). This supports findings of studies reporting on the overlap in 
genetic, neurobiological, and clinical features between schizophrenia and these psychiatric 
disorders94, 95.  
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Hallucinations caused by the abuse or withdrawal of substances (toxins, drugs, 
alcohol) differ from schizophrenia in the following features: visual hallucinations are more 
common than auditory hallucinations; the course is not recurrent but proximally related to 
substance ingestion; and hearing or vision loss is not a cause.   
A discussion on hallucinations in medical and neurological conditions is complicated 
by the heterogeneity of this group (incorporating tinnitus, epilepsy, narcolepsy, 
neurodegenerative conditions, and other medical and neurological conditions). Interestingly, 
conditions like epilepsy and tinnitus share up to 85% (18/21) of features with schizophrenia 
and appear almost indistinguishable in form and content60, 62, 86, 90, except for clinical and 
epidemiological correlates like trauma and external triggers. The absence of information on 
triggers may merely reflect the lack of direct comparison studies reporting on this issue. For 
example, photic stimulation, TV and video games are triggers for complex partial seizures96. 
Overall, too few direct comparisons exist for confident conclusions regarding unique 
hallucination features in medical and neurological conditions.  
Reflecting its relative newness as a field of research attention1, only seven studies 
involving non-clinical individuals met inclusion criteria. Hallucinations in this group shared 
11 out of 21 features with schizophrenia (52%), including vivid and frequent voices, third-
person hallucinations, personification, a recurrent course of hallucinations, and an increased 
risk for adverse negative events. A potential point of rarity distinguishing this nonclinical 
group is that such experiences receive a more positive interpretation compared to psychiatric 
disorders. Although contents may be negative97 in up to 50% of cases44, voices are more 
often positive (93% of cases compared with 83% in schizophrenia and 67% in dissociation 
identity disorder), and are largely controllable. The affective reaction to voices is also more 
positive in the nonclinical group. In the sample of evangelical born-again Christians50, voices 
are actively encouraged and given positive religious meanings. Such positive interpretations 
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are presumably consistent with reported reductions in daytime interference, agitation, and 
fear, and with the fact that such individuals do not seek care.  Several studies have now 
described the profile of non-clinical voice-hearers as varying on a continuum with voices in 
schizophrenia10, 47. Additional differences identified here include that (i) other modalities of 
hallucination (e.g., visual or body-related) may be as common as voices (or even more so); 
(ii) such individuals experience a lesser total number of different modalities of hallucinations 
(< 3); and (iii) hearing loss or visual deficits do not appear as a frequent cause.  
  Finally, Table 1 was examined to establish whether any hallucination features are 
shared among all but one diagnostic groups, suggesting a point of rarity for that exception 
group. This criterion was met only for the non-clinical group. Four out of 21 (21%) 
hallucination features were shared among all other groups except this one (hallucinations in 
≥3 sensory modalities, commands to commit aggressive or injurious acts, interference with 
daytime functions, and lack of perceived control).  
Interaction between features 
 The above analysis suggests that it is inadvisable to give weight to the presence of 
any featural properties alone in making a schizophrenia diagnosis. More important than the 
presence or absence of any specific hallucination features, however, is arguably the question 
of how those features interact with other symptoms. Two issues need to be distinguished 
here: the question of whether the specific profile of symptoms and symptom features create 
distinctive signatures for different diagnoses, and the question of how symptoms interact as 
they co-occur. In relation to the first question, Table 1 indicates how a transdiagnostic 
comparison of hallucination features may indicate distinctive profiles for particular disorders. 
Clearly, in distinguishing schizophrenia from (say) toxin-related disorders, other clinical 
information (such as patient history of toxin use) will be highly relevant. Further research in 
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transdiagnostic comparison of symptom features (beyond their mere absence or presence) 
may however be of value in improving differential diagnosis.  
With regard to the second question, there has recently been considerable interest in 
the view that psychotic symptoms occur transdiagnostically and that features of psychosis 
may occur on a continuum as an extended phenotype in the general population7. With the 
application of methodologies such as graph theory to psychosis research, new methodologies 
are becoming available to better understand psychosis as it operates within a network of 
interacting symptoms98. Most importantly, such methods demonstrate how, through 
investigation of interactions between variables, it is possible to understand how 
hallucinations may function or impact differently in different diagnostic groups according to 
what roles they play in the network. 
 
5.  Clinical applications 
This review yields an important conclusion with regard to the diagnostic value of 
hallucinations. It concludes that it is inadvisable to give weight to the presence of any 
featural properties of hallucination alone when making a diagnosis. For example, negative 
and hostile voices talking in the third person and causing distress may equally be present in a 
patient with schizophrenia, epilepsy, brain tumor, or PTSD. However, this conclusion does 
not entail that hallucinations are clinically uninformative. First, clinical observation suggests 
that some conditions have their own distinctive hallucination signature providing clues 
regarding their underlying causes (e.g., ‘cocaine bugs’55).  Second, the greater clinical 
significance of hallucinations may lie in their value in designating the severity of 
psychopathology. The presence of hallucinations indicates increased risk of poor outcomes 
transdiagnostically, including multimorbid non-psychotic disorders, suicidality, 
neurocognitive deficits, and low functioning6, 81. Functional disability is also higher in those 
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with hallucinations than those without hallucinations in the context of psychiatric disorders 
such as dissociative identity disorder44, PTSD75, anorexia nervosa78, and narcolepsy. In such 
cases, hallucinations may point to a more severe form of the disorder. Alternatively, 
hallucinations may be an experience that restricts patients’ recovery while not being intrinsic 
to that particular disorder, just as other factors such as educational level and social support 
will influence prognosis. Altogether, the value of hallucinations may be greater as an 
indicator of vulnerability or risk than as a diagnostic marker. 
 
6. Limitations and future directions  
Several limitations apply to the present study. Our inclusion criteria limit the parameters and 
features investigated to those that were reported in these 43 papers. Absence of a feature in 
Table 1 does not entail that it is a not a feature of the disorder, but rather indicates a lack of 
evidence on which to make comparisons. The range of features reviewed here is also 
necessarily limited. First, features tend to cluster in similar dimensions (physical properties, 
control, frequency, complexity, emotional reaction, special significance, etc.) which may 
exaggerate similarities across groups of interest. Second, some features such as the presence 
of multiple personified voices97, or the contents of visual hallucinations84, are not 
represented. Third, these features might not be the best way of describing 
psychopathological phenomena as natural kinds, but may rather represent categories imposed 
by psychiatric convention99. Our analysis focused on comparison studies involving two or 
more groups, which have generally adopted traditional approaches to symptom assessment. 
Other approaches that have used qualitative interviews and phenomenological approaches 
have revealed additional variables which do not figure in the above contrasts. It is possible 
that studies targeting variables such as changed aspects of self-consciousness, disturbed 
sense of internal space100, bodily sensations97, and thought-like properties of voices97, may 
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reveal hallucination features that are more discriminative of psychosis than those considered 
here. Furthermore, the present analysis might have had a different outcome if we had seeded 
our comparisons with a diagnostic group other than schizophrenia, such as Parkinson’s 
disease, where the features for comparison might have been significantly different. We could 
have also have adopted different criteria, such as comparison of hallucinations among two or 
more diagnostic groups without the requirement that one be schizophrenia. A final limitation 
is that the studies reviewed adopted widely varying measures and designs. Further progress 
in transdiagnostic comparison of hallucination features arguably requires consistency of 
measures across the groups studied101.  
Finally, we consider implications for cognitive and neuroscientific models of 
hallucinations. We noted at the outset that there is very limited evidence in the cognitive and 
neuroscientific domains on which to base transdiagnostic comparisons of hallucinations1. A 
further issue concerns the problem of mapping cognitive profiles of different groups to 
specific features of hallucinations, as opposed to their mere presence or absence. Most such 
research compares diagnostic groups with healthy controls, or (increasingly) uses 
hallucination incidence as an independent variable within a particular diagnostic group: for 
example, comparing schizophrenia patients with and without hallucinations.  
For these and other reasons, a discussion and comparison of cognitive and 
neurobiological models across diagnostic groups is beyond the scope of the present article. 
These are well developed models of hallucinations in schizophrenia 9 11, 102, 103, and in 
neurodegenerative disease such as Parkinson’s Disease104-106. A complication is that the 
models for these disorder groups are rather divergent, with some schizophrenia models 
proposing hyperactivity of the auditory cortex mediated by dopamine release, and 
Parkinson’s models proposing underactivity of the occipital cortex mediated by 
acetylcholine. No such models have been developed for other conditions except for non-
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clinical hallucinations, which some continuum approaches propose can be best understood as 
variants of schizophrenia models. Given the many featural similarities of hallucinations 
among the disorders discussed here, further effort is needed in developing and integrating 
neurocognitive models across diagnostic groups.  
 
7. Conclusions 
Hallucinations are a feature of human experience that crosses diagnostic category boundaries 
and straddles the divide between psychopathological and nonclinical experience. They occur 
widely across diagnostic disorders and their presence or absence is only clinically useful 
when considered in conjunction with other symptoms and clinically relevant data. There are 
no ‘points of rarity’ when we address the features of hallucinations in schizophrenia, with the 
possible exception of age of onset. We recommend that future studies should systematically 
ask about onset, and the conditions and context in which hallucination first occurred107, 108.  
Other features may be particularly valuable in distinguishing other disorders, but more 
research is needed which pays attention to phenomenological and clinical features of 
hallucinations, and compares them in methodologically robust designs across diagnostic 
groups and into the nonclinical population.  
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Figure 1. PRISMA diagram  
  Records identified through 
database searching 
N = 165 
Full text articles excluded with 
reasons: 
Cognitive studies n = 2; 
Neuroimaging studies n = 4; 
Not involving schizophrenia = 
3 (dementia, Parkinson 
Disease, narcolepsy); Not 
reporting on hallucinations = 4 
Articles included in final analyses 
 N = 43 
Additional records identified from other known 
articles  
N = 21 
Full-text articles assessed for 
eligibility  
N = 56 
Number of records screened 
N = 186 
Records excluded due to non-
suitability based from title to n 
= 130 
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Table 1: Phenomenological features of hallucinations across four population groups (mean %) and comparisons with schizophrenia (mean %92) 
(‘Nil’ findings shaded in grey) 
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Groups showing the same features as schizophrenia 
Form  
Presence of auditory verbal 
hallucinations (‘voices’) 
75% 58% 50% 32% 46–57% Non-clinical44, 45 48 (including evangelical born-again Christians50); alcohol  dependence disorder51 
56, cocaine withdrawal 55; tinnitus60, epilepsy62 83, medical or neurological condition63, narcolepsy35; 
Parkinson’s disease 84; bipolar disorder42 69 70, borderline personality disorder74 73, dissociative 
identity disorder77, PTSD75. 
Predominance of auditory (A) over 
visual  (V) hallucinations 
75% A, 
30% V 
Nil Nil 32% A, 
10% V 
28% A, 
15% V 
Temporal lobe epilepsy62 83, medical or neurological condition 86 63; bipolar disorder42  
Hallucinations in three or more sensory 
modalities 
60% Nil 16% 20% 76% Cocaine abuse55 , LSD intoxication54, alcohol dependence disorder53; bipolar disorder66, 70, 
dissociative identity disorder77, narcolepsy35 
Duration: up to several hours at a time  66% 47% ?%  70% 77%–
93% 
Non-clinical44 (including evangelical born-again Christians50); alcohol dependence disorder53, 
cocaine abuse 55; tinnitus60, temporal lobe epilepsy62; dissociative identity disorder44, borderline 
personality disorder73 
Perceived to be vivid and real 
 
80% ?%  26% 48% 54%–
100% 
Non-clinical44 28 48; alcohol dependence disorder51, cocaine abuse 55 56 59; LSD intoxication 58; 
tinnitus60, temporal lobe epilepsy62, 83, medical or neurological condition 63; PTSD76, bipolar disorder 
66 69 64, dissociative identity disorder44 77, borderline personality disorder74 73 72  
Originating in external space 50% 57% 70% 37% 60–83% Non-clinical44 28; alcohol dependence disorder51; tinnitus60, medical or neurological condition63; 
dissociative identity disorder77, PTSD76 77, bipolar disorder 66 69 8, 64, borderline personality 
disorder74 73 72  
Third-person hallucinations, running 
commentary, voices commenting 
65% 20%–
41% 
20%–
60% 
10%–
41% 
40–80% Non-clinical44 28; cannabis abuse57; alcohol dependence disorder53 56; medical or neurological 
condition 86 63, temporal lobe epilepsy62, 83; affective disorders69 69, dissociative identity disorder44, 
PTSD76 , borderline personality disorder74, narcolepsy35 
Hallucinations shared with other people 
(e.g., voices ’heard’ by others) 
 
50% Nil Nil 62% 27% Epilepsy 86 , neurological condition 66; bipolar disorder 66 69 
Contents 
Negative and hostile content 60% 43–53 ?%  33 % 58%–
93% 
Non-clinical44 48 (including evangelical born-again Christians50); cocaine withdrawal55, alcohol 
dependence disorder56 ; temporal lobe epilepsy62 ; Parkinson’s disease84; medical and neurological 
condition 63, affective disorders mixed 69; PTSD75 76, borderline personality disorder73 72; 
dissociative identity disorder44 77 
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Personifications and attributions to 
spiritual or magical identities  
61% 50%–
100% 
20%–
60% 
50% 97% Non-clinical28 46 (including evangelical born-again Christians50); cocaine withdrawal55; alcohol 
dependence disorder56; medical or neurological condition 63 64;  temporal lobe epilepsy62 ; PTSD76  
Assigned significance (e.g., 
hallucinations have meaning) 
72% ?% 42% 76% ?% Non-clinical (including evangelical born-again Christians50 and other religious voice-hearers49); 
cocaine withdrawal55, LSD intoxication54; temporal lobe epilepsy62; bipolar disorder64, borderline 
personality disorder71  
Commands to commit aggressive or 
injurious acts 
84% Nil 4% ?% 62%–
82% 
Cocaine withdrawal and dependence55 52, alcohol substance disorder 56; temporal lobe epilepsy62; 
bipolar disorder 69, PTSD 76, dissociative identity disorder77  
Interference and lack of control 
Interference with daytime functions 47% Nil 30% ?%  84% Cocaine withdrawal 
55; tinnitus60; temporal lobe epilepsy62; PTSD75 76, borderline personality 
disorder73 72, bipolar disorder64, narcolepsy35 
Lack of perceived control 
 
78% Nil ?%  53% 78% Alcohol substance disorder 51; tinnitus60, temporal lobe epilepsy62, 83, medical or neurological 
condition 66 64; borderline personality disorder73 72, bipolar disorder 66  69 
Other clinical and epidemiological features 
Recurrent course of hallucinations (> 1 
year, multiple episodes) 
60% 89% Nil ?% 35% Non-clinical47, 48; epilepsy62, 83; PTSD 76, bipolar disorder 88 68 
Hearing or vision loss ?%  Nil 
 
Nil ?%  ?% Tinnitus60, medical or neurological condition 65, 66, neurodegenerative disease 81; UHR psychosis79 
Trauma and neglect 50% 50% Nil Nil 50% Non-clinical population 44 47; dissociative identity disorder 44 77; borderline personality disorder73 72   
External triggers 50% Nil Nil Nil 80% Affective disorders69, dissociative identity disorder77 44 
Internal triggers  60% ?% ?%  ?% 60% Nonclinical population44; tinnitus60; all substances are internal triggers; PTSD76 
Family history of psychiatric illness 30% Nil 23% 30% 40% Epilepsy83; cannabis abuse 57; anorexia nervosa78  
Age of onset in late teen to early 
twenties 
18-24 Nil  Nil Nil Nil  
Feature commonality with 
schizophrenia (number and %) 
n/a 11/21 
= 52% 
14/21 
=66% 
18/21 
= 85% 
20/21 = 
95% 
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Supplementary Material Table 1. Occurrence of hallucinations  
 
Hallucinations in the general (non-clinical) population 
 
 
Non-clinical causes 
General population on a continuum; sleep-related experiences (lucid 
dreaming, hypnagogic and hypnagogic hallucinations, sleep deprivation); 
Induced by hypnosis, trance states; religious and ritual activities; 
sociocultural expectations and influences; bereavement; sensory isolation 
and solitary confinement; food deprivation; psychosocial adversity including 
childhood abuse; fatigue; life-threatening stress. 
Hallucinations caused by the effects of substances 
 
Substance-induced 
conditions (toxins, 
drugs and alcohol) 
Intoxication with stimulants (e.g., amphetamine, cocaine), hallucinogenic 
drugs (psilocybin, LSD; tryptamine; MDMA), mescaline, inhalants; 
phencyclidine (PCP), ketamine, cannabis; Withdrawal from alcohol, 
sedatives, hypnotic or anxiolytic medications; Substance dependence from 
alcohol and other drugs; Side-effect or abuse of glucocorticosteroids, 
attention-deficit/hyperactivity disorder (ADHD), antimalarials, 
antiparkinsonian drugs, benzodiazepine, anticonvulsants, antihypertensives, 
antiarrhythmic agents; antibiotics; anticholinergic agents; antipsychotics; 
opioids; Poisoning from mercury, arsenic, or lead. 
Hallucinations in medical and neurological conditions 
 
Ear and eye disorders 
 
Age-related macular degeneration, cataract, glaucoma or diabetic 
retinopathy (Charles Bonnet syndrome); tinnitus, hearing impairments or 
loss, disorder from damage to the auditory pathway or circuitry including 
brain stem. 
 
Metabolic and 
endocrine disorders  
 
Niemann-Pick type C; Tay Sachs disease; metachromatic leukodystrophy; 
Wilson’s disease; porphyria; adrenal disorders; hypothyroidism; 
hyperthyroidism; hypoparathyroidism, hyperparathyroidism; hypocalcaemia; 
thyrotoxicosis; premenstrual dysphoric disorder. 
Dietary deficiencies  Vitamin B12 deficiency; vitamin D deficiency; folic acid deficiencies; copper 
and zinc deficiencies. 
Congenital, 
chromosomal and 
cytogenetic disorders 
Velocardiofacial (22q11.2 deletion syndrome); Prader–Willi syndrome; 
Huntington’s disease; Wilson's disease; Fahr’s disease. 
Infectious diseases and 
autoimmune disorders 
Neurosyphilis; HIV/AIDS, toxoplasmosis; sarcoidosis, systemic lupus 
erythematosus; Hashimoto disease; NMDA receptor encephalitis. 
Neurological lesions, 
seizures, and 
cerebrovascular events 
Epilepsy; complex seizures; stroke; brain tumors; temporal lobectomy; other 
lesions involving the occipital and temporo-parietal pathways; mild 
neurocognitive disorder; vascular hematomas; intracerebral and 
arteriovenous malformations; meningiomas; encephalitis; traumatic brain 
injury; concussion syndrome; migraines; delirium. 
Neurodegenerative 
disorders  
Parkinson’s disease; Alzheimer’s disease; Dementia with Lewy Bodies 
(DLB); vascular dementia; frontotemporal dementia (FTD); prion disease; 
progressive supranuclear palsy; multiple sclerosis; pontine degeneration; 
delirium tremens. 
Hallucinations in psychiatric disorders 
Schizophrenia 
spectrum disorders  
 
 
Schizophrenia; schizoaffective disorder; delusional disorder; schizoid, 
paranoid and schizotypal (personality) disorder; schizophreniform disorder; 
brief psychotic disorder; other specified schizophrenia spectrum and other 
psychotic disorder.. 
Affective disorders Major depression with psychotic features; bipolar disorder type I and II. 
Personality disorders Borderline personality disorder 
Anxiety disorders, 
stressor-related 
disorders; dissociative 
disorders 
Anxiety disorders with psychotic features; phobias; dissociative disorders; 
obsessive-compulsive disorder; Tourette syndrome; post-traumatic stress 
disorder (PTSD), acute stress disorder; dissociative identity disorder. 
Neurodevelopmental 
disorder 
Autism; attention-deficit/hyperactivity disorder (ADHD); other disruptive 
behaviour disorders; other psychopathology including early onset 
schizophrenia and affective disorder. 
Eating disorders  Anorexia and bulimia nervosa; narcolepsy; sleep deprivation. 
Sleep-wake disorders Narcolepsy; sleep deprivation. 
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Supplementary material 2: List of studies included in systematic review  
Authors N  
SCZ1 
Comparison sample N 
Aggernaes et al 1972 41 LSD intoxication  26 
Alpert & Silvers 1970 45 Alcohol dependence disorder 18 
Baethge et al 2005 130 Bipolar disorder  Major depression with psychotic features 65 
Bell 1965 7 Cocaine dependence disorder 7 
Bliss 1962 * LSD intoxication * 
Bowman 1931 1408 Bipolar disorder  1009 
Brett et al 2015 37 Ultra-high risk (UHR) for psychosis 21 
Chaturvedi & Sinha 1990 18 Affective disorders mixed 30 
Cottam et al 2011 14 Non-clinical (religious Christians) 15 
Cutting 1987 74 Medical and neurological conditions mixed 74 
Daalman et al 2011 111 Non-clinical  118 
Davies et al 2011 18 Non-clinical (evangelical Christians) 29 
Dorahy et al 2009 34 Dissociative identity disorder 29 
Eagles et al 1990 88 Anorexia nervosa 73 
Frieske & Wilson 1966 50 Medical and neurological conditions mixed Affective disorder 
30 
15 
Fortuyn et al 2009 102 Narcolepsy 60 
Goodwin et al 1971 45 
Affective disorders  
Alcohol dependence disorder  
Medical and neurological conditions mixed 
28 
27 
9 
Hamner et al 2000 40 Post-traumatic stress disorder (PTSD) 40 
Hepworth et al 2013 23 Borderline personality disorder 10 
Honig et al 1998 18 Non-clinical  Dissociative identity disorder 
15 
15 
Jessop et al 2008 61 5 Post-traumatic stress disorder (PTSD) 13 
Johns et al 2002 14 Neurological (tinnitus) 16 
Johnstone et al 1988 43 Neurological disorders mixed Affective disorders 
22 
44 
Junginger & Frame 1985 52 Affective disorders 41 
Kimhy et al 2007 34 Ultra high risk (UHR) of psychosis 32 
Kingdon et al 2010 59 Borderline personality disorder 33 
Lindal et al 1994  19 Non clinical 187 
Leudar et al 1997 14 Non clinical  13 
Lowe 1973 15 Bipolar disorder Neurological disorders mixed 15 
Malitz et al 1962 100 LSD intoxication 34 
Mitchell & Vierkant 1991 100 Cocaine withdrawal 100 
Mott et al 1965 50 Alcohol dependence disorder 50 
Núñez & Gurpegui 2002 35 Cannabis abuse 26 
Okulate & Jones 2003 76 Affective disorders mixed 13 
Perez et al, 1985 7 Epilepsy 17 
Peters et al 2016 84 Non-clinical  92 
Shinn et al 2012 325 Bipolar disorder 244 
Slater & Beard 1963 46 Epilepsy 15 
Slotema et al 2012 51 Borderline personality disorder 38 
Standage 1973 2 Epilepsy 6 
Tschoeke et al 2014 21 Borderline personality disorder 23 
Waters et al 2014 α Parkinson’s disease Dementia Lewy Body 
α 
Young 1972 20 LSD intoxication 20 
1 Schizophrenia-spectrum (primarily schizophrenia, schizoaffective); * sample size not reported; α Comparisons made 
from literature review. 
 
 
